NAACCR Item #3809: AFP Pretreatment Interpretation
|Item #||Length||Source of Standard||Year Implemented||Version Implemented||Year Retired||Version Retired|
NAACCR XML: Tumor.afpPretreatmentInterpretation
AFP (Alpha Fetoprotein) Pretreatment Interpretation
AFP (Alpha Fetoprotein) Pretreatment Interpretation, a nonspecific serum protein that generally is elevated in the setting of hepatocellular carcinoma (HCC), is a prognostic factor for liver cancer.
AFP (Alpha Fetoprotein) Pretreatment Interpretation is a Registry Data Collection Variable in AJCC. This data item was previously collected for Liver, CS SSF# 1.
|0||Negative/normal; within normal limits|
|2||Borderline; undetermined if positive or negative|
|7||Test ordered, results not in chart|
|8||Not applicable: Information not collected for this case
(If this item is required by your standard setter, use of code 8 will result in an edit error.)
|9||Not documented in medical record
AFP pretreatment interpretation not assessed or unknown if assessed
Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.